

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.06296907 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.06296907 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.66083375 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.66083375 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.46934255 |
| 6 | tryptophan catabolic process (GO:0006569) | 4.95641497 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 4.95641497 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 4.95641497 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.78956901 |
| 10 | tryptophan metabolic process (GO:0006568) | 4.65349367 |
| 11 | kynurenine metabolic process (GO:0070189) | 4.63664591 |
| 12 | urea cycle (GO:0000050) | 4.49538651 |
| 13 | urea metabolic process (GO:0019627) | 4.49538651 |
| 14 | bile acid biosynthetic process (GO:0006699) | 4.49520239 |
| 15 | glyoxylate metabolic process (GO:0046487) | 4.44609175 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 4.43618483 |
| 17 | sulfur amino acid catabolic process (GO:0000098) | 4.36011698 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 4.33533524 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.31064843 |
| 20 | cysteine metabolic process (GO:0006534) | 4.24918235 |
| 21 | nitrogen cycle metabolic process (GO:0071941) | 4.21141440 |
| 22 | cellular ketone body metabolic process (GO:0046950) | 4.13271738 |
| 23 | amino-acid betaine metabolic process (GO:0006577) | 4.09398129 |
| 24 | regulation of sequestering of triglyceride (GO:0010889) | 4.07899520 |
| 25 | sperm motility (GO:0030317) | 4.05966598 |
| 26 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.02148888 |
| 27 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.98583014 |
| 28 | bile acid metabolic process (GO:0008206) | 3.98227184 |
| 29 | complement activation, alternative pathway (GO:0006957) | 3.95058932 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.94570340 |
| 31 | protein carboxylation (GO:0018214) | 3.94570340 |
| 32 | drug catabolic process (GO:0042737) | 3.94254400 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 3.91932729 |
| 34 | behavioral response to nicotine (GO:0035095) | 3.90695923 |
| 35 | homocysteine metabolic process (GO:0050667) | 3.87704412 |
| 36 | reverse cholesterol transport (GO:0043691) | 3.86819832 |
| 37 | tyrosine metabolic process (GO:0006570) | 3.85077842 |
| 38 | negative regulation of sterol transport (GO:0032372) | 3.83485187 |
| 39 | negative regulation of cholesterol transport (GO:0032375) | 3.83485187 |
| 40 | alpha-amino acid catabolic process (GO:1901606) | 3.81925867 |
| 41 | lysine metabolic process (GO:0006553) | 3.81237186 |
| 42 | lysine catabolic process (GO:0006554) | 3.81237186 |
| 43 | serine family amino acid catabolic process (GO:0009071) | 3.80640076 |
| 44 | regulation of fibrinolysis (GO:0051917) | 3.80020550 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 3.79946673 |
| 46 | response to epinephrine (GO:0071871) | 3.79884187 |
| 47 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.78745937 |
| 48 | glutamate metabolic process (GO:0006536) | 3.78589403 |
| 49 | negative regulation of fibrinolysis (GO:0051918) | 3.73523752 |
| 50 | plasma lipoprotein particle remodeling (GO:0034369) | 3.73389722 |
| 51 | protein-lipid complex remodeling (GO:0034368) | 3.73389722 |
| 52 | macromolecular complex remodeling (GO:0034367) | 3.73389722 |
| 53 | organic cation transport (GO:0015695) | 3.72460522 |
| 54 | cellular response to epinephrine stimulus (GO:0071872) | 3.71416992 |
| 55 | drug transmembrane transport (GO:0006855) | 3.69623807 |
| 56 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.68415321 |
| 57 | short-chain fatty acid metabolic process (GO:0046459) | 3.65060501 |
| 58 | regulation of protein activation cascade (GO:2000257) | 3.61254908 |
| 59 | fatty acid transmembrane transport (GO:1902001) | 3.60570918 |
| 60 | regulation of cholesterol esterification (GO:0010872) | 3.59627941 |
| 61 | cellular amino acid catabolic process (GO:0009063) | 3.59323836 |
| 62 | ketone body metabolic process (GO:1902224) | 3.59301899 |
| 63 | interkinetic nuclear migration (GO:0022027) | 3.58935363 |
| 64 | indolalkylamine metabolic process (GO:0006586) | 3.57522231 |
| 65 | coenzyme catabolic process (GO:0009109) | 3.56559085 |
| 66 | exogenous drug catabolic process (GO:0042738) | 3.55478942 |
| 67 | cellular modified amino acid catabolic process (GO:0042219) | 3.54593799 |
| 68 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.50972325 |
| 69 | cellular biogenic amine catabolic process (GO:0042402) | 3.50216439 |
| 70 | amine catabolic process (GO:0009310) | 3.50216439 |
| 71 | negative regulation of lipase activity (GO:0060192) | 3.48346841 |
| 72 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.47531818 |
| 73 | cAMP catabolic process (GO:0006198) | 3.47223649 |
| 74 | acylglycerol homeostasis (GO:0055090) | 3.42095011 |
| 75 | triglyceride homeostasis (GO:0070328) | 3.42095011 |
| 76 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.38274203 |
| 77 | phospholipid efflux (GO:0033700) | 3.37734089 |
| 78 | cellular glucuronidation (GO:0052695) | 3.37561824 |
| 79 | acrosome reaction (GO:0007340) | 3.37376909 |
| 80 | plasma lipoprotein particle clearance (GO:0034381) | 3.36476286 |
| 81 | bile acid and bile salt transport (GO:0015721) | 3.36163371 |
| 82 | positive regulation of fatty acid oxidation (GO:0046321) | 3.35521195 |
| 83 | regulation of complement activation (GO:0030449) | 3.34276269 |
| 84 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.33680318 |
| 85 | cholesterol efflux (GO:0033344) | 3.33347251 |
| 86 | benzene-containing compound metabolic process (GO:0042537) | 3.30406935 |
| 87 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.23832169 |
| 88 | relaxation of cardiac muscle (GO:0055119) | 3.20300347 |
| 89 | detection of calcium ion (GO:0005513) | 3.20206863 |
| 90 | positive regulation of action potential (GO:0045760) | 3.18956058 |
| 91 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.18487318 |
| 92 | carboxylic acid catabolic process (GO:0046395) | 3.16943441 |
| 93 | organic acid catabolic process (GO:0016054) | 3.16943441 |
| 94 | aspartate family amino acid catabolic process (GO:0009068) | 3.15261971 |
| 95 | cell wall macromolecule metabolic process (GO:0044036) | 3.14976835 |
| 96 | cell wall macromolecule catabolic process (GO:0016998) | 3.14976835 |
| 97 | carnitine metabolic process (GO:0009437) | 3.14949975 |
| 98 | cyclic nucleotide catabolic process (GO:0009214) | 3.14083404 |
| 99 | positive regulation of heart rate (GO:0010460) | 3.13550582 |
| 100 | flavonoid metabolic process (GO:0009812) | 3.09198435 |
| 101 | regulation of cell communication by electrical coupling (GO:0010649) | 3.08258681 |
| 102 | low-density lipoprotein particle remodeling (GO:0034374) | 3.07314297 |
| 103 | urate metabolic process (GO:0046415) | 3.07059858 |
| 104 | positive regulation of lipid catabolic process (GO:0050996) | 3.05735759 |
| 105 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.05557976 |
| 106 | glucuronate metabolic process (GO:0019585) | 3.03750042 |
| 107 | uronic acid metabolic process (GO:0006063) | 3.03750042 |
| 108 | regulation of sarcomere organization (GO:0060297) | 3.03244090 |
| 109 | acetyl-CoA metabolic process (GO:0006084) | 3.02651755 |
| 110 | indole-containing compound metabolic process (GO:0042430) | 3.01969289 |
| 111 | response to mercury ion (GO:0046689) | 3.00552416 |
| 112 | myofibril assembly (GO:0030239) | 3.00004244 |
| 113 | cardiac myofibril assembly (GO:0055003) | 2.99330269 |
| 114 | nucleobase catabolic process (GO:0046113) | 2.97533958 |
| 115 | cofactor catabolic process (GO:0051187) | 2.96139909 |
| 116 | ethanol oxidation (GO:0006069) | 2.96042560 |
| 117 | monocarboxylic acid catabolic process (GO:0072329) | 2.95585298 |
| 118 | fibrinolysis (GO:0042730) | 2.94528589 |
| 119 | drug transport (GO:0015893) | 2.93422624 |
| 120 | carnitine shuttle (GO:0006853) | 2.92195324 |
| 121 | multicellular organism reproduction (GO:0032504) | 2.92107289 |
| 122 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.91877345 |
| 123 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.91877345 |
| 124 | fatty acid oxidation (GO:0019395) | 2.90677361 |
| 125 | drug metabolic process (GO:0017144) | 2.89341539 |
| 126 | arginine metabolic process (GO:0006525) | 2.89023946 |
| 127 | regulation of relaxation of muscle (GO:1901077) | 2.87496488 |
| 128 | neuronal action potential (GO:0019228) | 2.86720204 |
| 129 | response to caffeine (GO:0031000) | 2.83003013 |
| 130 | regulation of cardiac muscle contraction (GO:0055117) | 2.81403095 |
| 131 | sarcomere organization (GO:0045214) | 2.75658284 |
| 132 | pericardium development (GO:0060039) | 2.75365522 |
| 133 | regulation of striated muscle contraction (GO:0006942) | 2.74916143 |
| 134 | serotonin metabolic process (GO:0042428) | 2.74502375 |
| 135 | fucose catabolic process (GO:0019317) | 2.74070996 |
| 136 | L-fucose metabolic process (GO:0042354) | 2.74070996 |
| 137 | L-fucose catabolic process (GO:0042355) | 2.74070996 |
| 138 | regulation of energy homeostasis (GO:2000505) | 2.73569564 |
| 139 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.73077634 |
| 140 | adrenergic receptor signaling pathway (GO:0071875) | 2.67519842 |
| 141 | sulfation (GO:0051923) | 2.65616996 |
| 142 | regulation of action potential (GO:0098900) | 2.63969376 |
| 143 | regulation of actin filament-based movement (GO:1903115) | 2.60774726 |
| 144 | neural tube formation (GO:0001841) | 2.55910215 |
| 145 | regulation of pigment cell differentiation (GO:0050932) | 2.55103301 |
| 146 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.54572869 |
| 147 | regulation of membrane repolarization (GO:0060306) | 2.54505048 |
| 148 | membrane depolarization during action potential (GO:0086010) | 2.51251299 |
| 149 | urinary tract smooth muscle contraction (GO:0014848) | 2.50399973 |
| 150 | regulation of establishment of cell polarity (GO:2000114) | 2.47987136 |
| 151 | reflex (GO:0060004) | 2.47596064 |
| 152 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.47009149 |
| 153 | positive regulation of glycolytic process (GO:0045821) | 2.46730109 |
| 154 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.46706665 |
| 155 | primary amino compound metabolic process (GO:1901160) | 2.45492283 |
| 156 | cellular response to ethanol (GO:0071361) | 2.43807317 |
| 157 | activated T cell proliferation (GO:0050798) | 2.43786540 |
| 158 | positive regulation of cation channel activity (GO:2001259) | 2.40806618 |
| 159 | cardiac muscle hypertrophy (GO:0003300) | 2.39510929 |
| 160 | adult heart development (GO:0007512) | 2.37502395 |
| 161 | establishment of protein localization to Golgi (GO:0072600) | 2.37444334 |
| 162 | action potential (GO:0001508) | 2.37295377 |
| 163 | cardiac muscle contraction (GO:0060048) | 2.35341991 |
| 164 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.33837472 |
| 165 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.30973587 |
| 166 | signal peptide processing (GO:0006465) | 2.30948678 |
| 167 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.29717090 |
| 168 | striated muscle hypertrophy (GO:0014897) | 2.29501513 |
| 169 | renal tubule morphogenesis (GO:0061333) | 2.27414723 |
| 170 | positive regulation of phosphatase activity (GO:0010922) | 2.27308284 |
| 171 | regulation of fatty acid oxidation (GO:0046320) | 2.27185628 |
| 172 | cardiovascular system development (GO:0072358) | 2.27104889 |
| 173 | regulation of lipoprotein metabolic process (GO:0050746) | 2.25895129 |
| 174 | carnitine transmembrane transport (GO:1902603) | 2.25232806 |
| 175 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.25129661 |
| 176 | parturition (GO:0007567) | 2.24042556 |
| 177 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.22689291 |
| 178 | regulation of the force of heart contraction (GO:0002026) | 2.20522456 |
| 179 | nephron epithelium morphogenesis (GO:0072088) | 2.19211061 |
| 180 | nephron tubule morphogenesis (GO:0072078) | 2.19211061 |
| 181 | cGMP-mediated signaling (GO:0019934) | 2.19208358 |
| 182 | regulation of heart rate (GO:0002027) | 2.19036970 |
| 183 | polyol transport (GO:0015791) | 2.18980044 |
| 184 | adult feeding behavior (GO:0008343) | 2.18276657 |
| 185 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.18033875 |
| 186 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.18007045 |
| 187 | toxin metabolic process (GO:0009404) | 2.18004498 |
| 188 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.17942559 |
| 189 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.17942559 |
| 190 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.17906282 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.19377729 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.81239101 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.27767340 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.25532384 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.07510225 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.82035709 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.78780311 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.54518496 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.45688670 |
| 10 | * GBX2_23144817_ChIP-Seq_PC3_Human | 2.42186092 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.21859989 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.19266179 |
| 13 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.15503383 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.14367703 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.13012983 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.07282281 |
| 17 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.03150554 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.88946638 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.83973509 |
| 20 | FUS_26573619_Chip-Seq_HEK293_Human | 1.73134823 |
| 21 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.72624969 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.67179699 |
| 23 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.67156475 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.64874824 |
| 25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60127303 |
| 26 | TP53_16413492_ChIP-PET_HCT116_Human | 1.59171942 |
| 27 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.58174848 |
| 28 | EWS_26573619_Chip-Seq_HEK293_Human | 1.49701153 |
| 29 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.49208559 |
| 30 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.47331864 |
| 31 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44190885 |
| 32 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.43462584 |
| 33 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.39611701 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.38387251 |
| 35 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.37718001 |
| 36 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.36869408 |
| 37 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.36003698 |
| 38 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.34154435 |
| 39 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.32171779 |
| 40 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.32147962 |
| 41 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.31041591 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.29597846 |
| 43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.29425447 |
| 44 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.28448607 |
| 45 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.28448607 |
| 46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.28313757 |
| 47 | CJUN_26792858_Chip-Seq_BT549_Human | 1.27154199 |
| 48 | P300_19829295_ChIP-Seq_ESCs_Human | 1.26449753 |
| 49 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.26433868 |
| 50 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.26247887 |
| 51 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.26078135 |
| 52 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.25257044 |
| 53 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.24900715 |
| 54 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.23343151 |
| 55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22870808 |
| 56 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22821065 |
| 57 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.21943723 |
| 58 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.21385616 |
| 59 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21004584 |
| 60 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.20195316 |
| 61 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.19867554 |
| 62 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.19639182 |
| 63 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.18255626 |
| 64 | RXR_22108803_ChIP-Seq_LS180_Human | 1.18011062 |
| 65 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.17629872 |
| 66 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.17363713 |
| 67 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.17230056 |
| 68 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.16784744 |
| 69 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.16546700 |
| 70 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.16484856 |
| 71 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.15644445 |
| 72 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.15457224 |
| 73 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.14522180 |
| 74 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13771953 |
| 75 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.13243083 |
| 76 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12947859 |
| 77 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12738139 |
| 78 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.12708736 |
| 79 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.12466306 |
| 80 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.12279953 |
| 81 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.11787748 |
| 82 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.11690234 |
| 83 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.11201972 |
| 84 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10407548 |
| 85 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10260474 |
| 86 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09235118 |
| 87 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.08882397 |
| 88 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.08704919 |
| 89 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07652836 |
| 90 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.07280556 |
| 91 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.07178586 |
| 92 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.07100884 |
| 93 | * VDR_22108803_ChIP-Seq_LS180_Human | 1.07098391 |
| 94 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06744395 |
| 95 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.06137726 |
| 96 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.05362912 |
| 97 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.05130600 |
| 98 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.04720664 |
| 99 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.04478240 |
| 100 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.04124498 |
| 101 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.03747992 |
| 102 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03130978 |
| 103 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.02745627 |
| 104 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.01184404 |
| 105 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00527676 |
| 106 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00527676 |
| 107 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00503843 |
| 108 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.99796879 |
| 109 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.99796879 |
| 110 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.99579481 |
| 111 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99410985 |
| 112 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.98531119 |
| 113 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.98148769 |
| 114 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.97629632 |
| 115 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.97629632 |
| 116 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.97537428 |
| 117 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.96327284 |
| 118 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95062360 |
| 119 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.94918250 |
| 120 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94027300 |
| 121 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.94002954 |
| 122 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.93226737 |
| 123 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.93171020 |
| 124 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92955759 |
| 125 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.92900450 |
| 126 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.92388865 |
| 127 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.92307862 |
| 128 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.91810401 |
| 129 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.90298620 |
| 130 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.90075931 |
| 131 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90020627 |
| 132 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.90007786 |
| 133 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.89789415 |
| 134 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.89739697 |
| 135 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.89542226 |
| 136 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.89056895 |
| 137 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.87879734 |
| 138 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.87371932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.80622705 |
| 2 | MP0005360_urolithiasis | 6.24867736 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.15451043 |
| 4 | MP0005365_abnormal_bile_salt | 5.07621324 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.73049563 |
| 6 | MP0000569_abnormal_digit_pigmentation | 4.12932825 |
| 7 | MP0005410_abnormal_fertilization | 3.62265886 |
| 8 | MP0004215_abnormal_myocardial_fiber | 3.46762078 |
| 9 | MP0004084_abnormal_cardiac_muscle | 3.31171794 |
| 10 | MP0003252_abnormal_bile_duct | 3.08435482 |
| 11 | MP0003646_muscle_fatigue | 2.99854544 |
| 12 | MP0003195_calcinosis | 2.97186403 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.90316443 |
| 14 | MP0005332_abnormal_amino_acid | 2.72928981 |
| 15 | MP0004484_altered_response_of | 2.51722156 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.36557304 |
| 17 | MP0005670_abnormal_white_adipose | 2.18713154 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 2.14698881 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.10073931 |
| 20 | MP0005503_abnormal_tendon_morphology | 2.03706297 |
| 21 | MP0005083_abnormal_biliary_tract | 2.00861440 |
| 22 | MP0004036_abnormal_muscle_relaxation | 1.99272385 |
| 23 | MP0003950_abnormal_plasma_membrane | 1.94771203 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 1.88631292 |
| 25 | MP0008775_abnormal_heart_ventricle | 1.80187417 |
| 26 | MP0003868_abnormal_feces_composition | 1.79328097 |
| 27 | MP0004510_myositis | 1.76320826 |
| 28 | MP0003137_abnormal_impulse_conducting | 1.75769290 |
| 29 | MP0004043_abnormal_pH_regulation | 1.74282227 |
| 30 | MP0010386_abnormal_urinary_bladder | 1.70593455 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.70312826 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.66291319 |
| 33 | MP0009840_abnormal_foam_cell | 1.61850551 |
| 34 | MP0005647_abnormal_sex_gland | 1.60245051 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.59408691 |
| 36 | MP0000751_myopathy | 1.56887816 |
| 37 | MP0001764_abnormal_homeostasis | 1.56652704 |
| 38 | MP0004142_abnormal_muscle_tone | 1.56141319 |
| 39 | MP0005620_abnormal_muscle_contractility | 1.54818064 |
| 40 | MP0006138_congestive_heart_failure | 1.52719580 |
| 41 | MP0000609_abnormal_liver_physiology | 1.51392043 |
| 42 | MP0004859_abnormal_synaptic_plasticity | 1.49100965 |
| 43 | MP0005451_abnormal_body_composition | 1.47700244 |
| 44 | MP0000427_abnormal_hair_cycle | 1.46680721 |
| 45 | MP0001544_abnormal_cardiovascular_syste | 1.46154918 |
| 46 | MP0005385_cardiovascular_system_phenoty | 1.46154918 |
| 47 | MP0004085_abnormal_heartbeat | 1.45652625 |
| 48 | MP0003045_fibrosis | 1.43284877 |
| 49 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.42135803 |
| 50 | MP0005319_abnormal_enzyme/_coenzyme | 1.41803710 |
| 51 | MP0003959_abnormal_lean_body | 1.39688650 |
| 52 | MP0002972_abnormal_cardiac_muscle | 1.39505532 |
| 53 | MP0005636_abnormal_mineral_homeostasis | 1.37920799 |
| 54 | MP0001765_abnormal_ion_homeostasis | 1.37678161 |
| 55 | MP0003880_abnormal_central_pattern | 1.37591986 |
| 56 | MP0009643_abnormal_urine_homeostasis | 1.32673303 |
| 57 | MP0005275_abnormal_skin_tensile | 1.32233927 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.31878381 |
| 59 | MP0002332_abnormal_exercise_endurance | 1.26906144 |
| 60 | MP0003690_abnormal_glial_cell | 1.26485091 |
| 61 | MP0004924_abnormal_behavior | 1.26084897 |
| 62 | MP0005386_behavior/neurological_phenoty | 1.26084897 |
| 63 | MP0000604_amyloidosis | 1.26021982 |
| 64 | MP0005535_abnormal_body_temperature | 1.20406117 |
| 65 | MP0003698_abnormal_male_reproductive | 1.19442757 |
| 66 | MP0003329_amyloid_beta_deposits | 1.17853643 |
| 67 | MP0003828_pulmonary_edema | 1.17679118 |
| 68 | MP0005174_abnormal_tail_pigmentation | 1.17414289 |
| 69 | MP0008961_abnormal_basal_metabolism | 1.16918244 |
| 70 | MP0010368_abnormal_lymphatic_system | 1.16515798 |
| 71 | MP0003136_yellow_coat_color | 1.16000255 |
| 72 | MP0003724_increased_susceptibility_to | 1.15423955 |
| 73 | MP0005171_absent_coat_pigmentation | 1.13985908 |
| 74 | MP0009697_abnormal_copulation | 1.12520679 |
| 75 | MP0001879_abnormal_lymphatic_vessel | 1.11697883 |
| 76 | MP0001756_abnormal_urination | 1.10762374 |
| 77 | MP0009745_abnormal_behavioral_response | 1.10023332 |
| 78 | MP0002736_abnormal_nociception_after | 1.08833590 |
| 79 | MP0004145_abnormal_muscle_electrophysio | 1.06808589 |
| 80 | MP0005595_abnormal_vascular_smooth | 1.05568393 |
| 81 | MP0004130_abnormal_muscle_cell | 1.04737921 |
| 82 | MP0001968_abnormal_touch/_nociception | 1.03920143 |
| 83 | MP0009764_decreased_sensitivity_to | 0.98953554 |
| 84 | MP0009115_abnormal_fat_cell | 0.98689838 |
| 85 | MP0000749_muscle_degeneration | 0.98391722 |
| 86 | MP0003635_abnormal_synaptic_transmissio | 0.98334266 |
| 87 | MP0009046_muscle_twitch | 0.98324948 |
| 88 | MP0002063_abnormal_learning/memory/cond | 0.94929360 |
| 89 | MP0005253_abnormal_eye_physiology | 0.93581751 |
| 90 | MP0001486_abnormal_startle_reflex | 0.93393028 |
| 91 | MP0001440_abnormal_grooming_behavior | 0.93023597 |
| 92 | MP0002572_abnormal_emotion/affect_behav | 0.91476739 |
| 93 | MP0002064_seizures | 0.91202320 |
| 94 | MP0002933_joint_inflammation | 0.90683272 |
| 95 | MP0002735_abnormal_chemical_nociception | 0.89659426 |
| 96 | MP0001501_abnormal_sleep_pattern | 0.89221259 |
| 97 | MP0001986_abnormal_taste_sensitivity | 0.89044726 |
| 98 | MP0001958_emphysema | 0.88721019 |
| 99 | MP0001485_abnormal_pinna_reflex | 0.88583496 |
| 100 | MP0005266_abnormal_metabolism | 0.88110682 |
| 101 | MP0003279_aneurysm | 0.87827917 |
| 102 | MP0002971_abnormal_brown_adipose | 0.86725414 |
| 103 | MP0002822_catalepsy | 0.85695217 |
| 104 | MP0001984_abnormal_olfaction | 0.85287008 |
| 105 | MP0005187_abnormal_penis_morphology | 0.85235025 |
| 106 | MP0001661_extended_life_span | 0.85190805 |
| 107 | MP0004270_analgesia | 0.83218253 |
| 108 | MP0002168_other_aberrant_phenotype | 0.83197317 |
| 109 | MP0008004_abnormal_stomach_pH | 0.82856019 |
| 110 | MP0009780_abnormal_chondrocyte_physiolo | 0.82584399 |
| 111 | MP0005334_abnormal_fat_pad | 0.82569987 |
| 112 | MP0005330_cardiomyopathy | 0.82208185 |
| 113 | MP0003763_abnormal_thymus_physiology | 0.81071726 |
| 114 | MP0003011_delayed_dark_adaptation | 0.79654705 |
| 115 | MP0004885_abnormal_endolymph | 0.78865072 |
| 116 | MP0008874_decreased_physiological_sensi | 0.78548798 |
| 117 | MP0003633_abnormal_nervous_system | 0.78471253 |
| 118 | MP0002106_abnormal_muscle_physiology | 0.78262358 |
| 119 | MP0005165_increased_susceptibility_to | 0.78252366 |
| 120 | MP0002254_reproductive_system_inflammat | 0.77480620 |
| 121 | MP0002009_preneoplasia | 0.76175947 |
| 122 | MP0009642_abnormal_blood_homeostasis | 0.75647866 |
| 123 | MP0009765_abnormal_xenobiotic_induced | 0.75210449 |
| 124 | MP0001929_abnormal_gametogenesis | 0.74615516 |
| 125 | MP0006072_abnormal_retinal_apoptosis | 0.73877971 |
| 126 | MP0005164_abnormal_response_to | 0.73124985 |
| 127 | MP0005369_muscle_phenotype | 0.73044517 |
| 128 | MP0003656_abnormal_erythrocyte_physiolo | 0.72715254 |
| 129 | MP0002078_abnormal_glucose_homeostasis | 0.72559401 |
| 130 | MP0002136_abnormal_kidney_physiology | 0.72273646 |
| 131 | MP0005646_abnormal_pituitary_gland | 0.72188684 |
| 132 | MP0008872_abnormal_physiological_respon | 0.71434667 |
| 133 | MP0000372_irregular_coat_pigmentation | 0.71139675 |
| 134 | MP0002108_abnormal_muscle_morphology | 0.69275806 |
| 135 | MP0002909_abnormal_adrenal_gland | 0.68862379 |
| 136 | MP0004883_abnormal_blood_vessel | 0.67829832 |
| 137 | MP0002102_abnormal_ear_morphology | 0.67782610 |
| 138 | MP0005084_abnormal_gallbladder_morpholo | 0.67696828 |
| 139 | MP0003879_abnormal_hair_cell | 0.67462841 |
| 140 | MP0000230_abnormal_systemic_arterial | 0.67364090 |
| 141 | MP0009384_cardiac_valve_regurgitation | 0.65932275 |
| 142 | MP0001664_abnormal_digestion | 0.65922633 |
| 143 | MP0002272_abnormal_nervous_system | 0.65901227 |
| 144 | MP0005666_abnormal_adipose_tissue | 0.65778969 |
| 145 | MP0002067_abnormal_sensory_capabilities | 0.65373785 |
| 146 | MP0002127_abnormal_cardiovascular_syste | 0.63461487 |
| 147 | MP0002161_abnormal_fertility/fecundity | 0.62448926 |
| 148 | MP0000538_abnormal_urinary_bladder | 0.59844777 |
| 149 | MP0000598_abnormal_liver_morphology | 0.59671793 |
| 150 | MP0003075_altered_response_to | 0.59553154 |
| 151 | MP0002069_abnormal_eating/drinking_beha | 0.57529448 |
| 152 | MP0003631_nervous_system_phenotype | 0.57117937 |
| 153 | MP0006276_abnormal_autonomic_nervous | 0.56598931 |
| 154 | MP0009763_increased_sensitivity_to | 0.56520392 |
| 155 | MP0003186_abnormal_redox_activity | 0.56474268 |
| 156 | MP0002557_abnormal_social/conspecific_i | 0.56344519 |
| 157 | MP0003953_abnormal_hormone_level | 0.55753200 |
| 158 | MP0005551_abnormal_eye_electrophysiolog | 0.54573467 |
| 159 | MP0005448_abnormal_energy_balance | 0.54347546 |
| 160 | MP0008469_abnormal_protein_level | 0.52927986 |
| 161 | MP0004742_abnormal_vestibular_system | 0.52837876 |
| 162 | MP0003638_abnormal_response/metabolism_ | 0.52316606 |
| 163 | MP0002734_abnormal_mechanical_nocicepti | 0.51332127 |
| 164 | MP0000920_abnormal_myelination | 0.50278247 |
| 165 | MP0002837_dystrophic_cardiac_calcinosis | 0.49603869 |
| 166 | MP0002928_abnormal_bile_duct | 0.49340670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.41394877 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.38122725 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 5.11189015 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.99792363 |
| 5 | Absent/shortened dynein arms (HP:0200106) | 4.77420252 |
| 6 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.77420252 |
| 7 | Xanthomatosis (HP:0000991) | 4.53250666 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.48904765 |
| 9 | Sudden death (HP:0001699) | 4.31499921 |
| 10 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.27309353 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.19422113 |
| 12 | Atrial fibrillation (HP:0005110) | 4.16914114 |
| 13 | Hypobetalipoproteinemia (HP:0003563) | 4.11868897 |
| 14 | Bundle branch block (HP:0011710) | 4.08613581 |
| 15 | Complement deficiency (HP:0004431) | 4.08007823 |
| 16 | Joint hemorrhage (HP:0005261) | 3.97638445 |
| 17 | Ketosis (HP:0001946) | 3.80382187 |
| 18 | Epidermoid cyst (HP:0200040) | 3.80322576 |
| 19 | Primary atrial arrhythmia (HP:0001692) | 3.72353226 |
| 20 | Pancreatic cysts (HP:0001737) | 3.70683261 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.63840222 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.54688004 |
| 23 | Hyperammonemia (HP:0001987) | 3.53306300 |
| 24 | Syncope (HP:0001279) | 3.50167197 |
| 25 | Supraventricular tachycardia (HP:0004755) | 3.43528104 |
| 26 | Hyperglycinuria (HP:0003108) | 3.43298372 |
| 27 | Hyperglycinemia (HP:0002154) | 3.38354992 |
| 28 | Supraventricular arrhythmia (HP:0005115) | 3.34439342 |
| 29 | Hyperventilation (HP:0002883) | 3.30697996 |
| 30 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.29999864 |
| 31 | Hypolipoproteinemia (HP:0010981) | 3.29516835 |
| 32 | Abnormality of methionine metabolism (HP:0010901) | 3.29350703 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.28476951 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.28128420 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 3.28128420 |
| 36 | Hypoalphalipoproteinemia (HP:0003233) | 3.19292840 |
| 37 | Congenital stationary night blindness (HP:0007642) | 3.11142970 |
| 38 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.10731861 |
| 39 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.10628694 |
| 40 | Hypercholesterolemia (HP:0003124) | 3.06719693 |
| 41 | Abnormality of the common coagulation pathway (HP:0010990) | 3.05759548 |
| 42 | Pancreatic fibrosis (HP:0100732) | 3.00388744 |
| 43 | Alkalosis (HP:0001948) | 3.00329102 |
| 44 | Genetic anticipation (HP:0003743) | 2.97550326 |
| 45 | Decreased circulating renin level (HP:0003351) | 2.95596474 |
| 46 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.94083637 |
| 47 | Abnormality of alanine metabolism (HP:0010916) | 2.94083637 |
| 48 | Hyperalaninemia (HP:0003348) | 2.94083637 |
| 49 | Gout (HP:0001997) | 2.93706064 |
| 50 | Tubular atrophy (HP:0000092) | 2.91966290 |
| 51 | Fat malabsorption (HP:0002630) | 2.90024013 |
| 52 | Congenital, generalized hypertrichosis (HP:0004540) | 2.89584072 |
| 53 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.89493144 |
| 54 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.89493144 |
| 55 | Hypokalemic alkalosis (HP:0001949) | 2.88498254 |
| 56 | True hermaphroditism (HP:0010459) | 2.84918268 |
| 57 | Abnormality of complement system (HP:0005339) | 2.83162742 |
| 58 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.82534172 |
| 59 | Vascular calcification (HP:0004934) | 2.81939250 |
| 60 | Congenital sensorineural hearing impairment (HP:0008527) | 2.80632595 |
| 61 | Progressive cerebellar ataxia (HP:0002073) | 2.73931473 |
| 62 | Abnormality of midbrain morphology (HP:0002418) | 2.73057750 |
| 63 | Molar tooth sign on MRI (HP:0002419) | 2.73057750 |
| 64 | Metabolic alkalosis (HP:0200114) | 2.69726081 |
| 65 | Abnormality of purine metabolism (HP:0004352) | 2.68324128 |
| 66 | Abnormality of renin-angiotensin system (HP:0000847) | 2.67648170 |
| 67 | Ketoacidosis (HP:0001993) | 2.67430225 |
| 68 | Abnormal ciliary motility (HP:0012262) | 2.66469606 |
| 69 | Abnormality of the intrinsic pathway (HP:0010989) | 2.64328150 |
| 70 | Lipoatrophy (HP:0100578) | 2.64102162 |
| 71 | Prolonged QT interval (HP:0001657) | 2.63041969 |
| 72 | Abnormality of nucleobase metabolism (HP:0010932) | 2.60497408 |
| 73 | Papilledema (HP:0001085) | 2.59993566 |
| 74 | Abnormal urine output (HP:0012590) | 2.59723991 |
| 75 | Increased circulating renin level (HP:0000848) | 2.59402074 |
| 76 | Abnormality of the renal medulla (HP:0100957) | 2.58805056 |
| 77 | Hyporeflexia of lower limbs (HP:0002600) | 2.56892820 |
| 78 | Ventricular tachycardia (HP:0004756) | 2.56833304 |
| 79 | Delayed CNS myelination (HP:0002188) | 2.56564224 |
| 80 | Left ventricular hypertrophy (HP:0001712) | 2.56407187 |
| 81 | Gaze-evoked nystagmus (HP:0000640) | 2.52669813 |
| 82 | Abnormality of renal excretion (HP:0011036) | 2.51741998 |
| 83 | Clumsiness (HP:0002312) | 2.51564585 |
| 84 | Glomerulonephritis (HP:0000099) | 2.50732566 |
| 85 | Heart block (HP:0012722) | 2.49827428 |
| 86 | Hyperaldosteronism (HP:0000859) | 2.49634874 |
| 87 | Hypothermia (HP:0002045) | 2.48166474 |
| 88 | Hyperactive renin-angiotensin system (HP:0000841) | 2.48096484 |
| 89 | Spontaneous abortion (HP:0005268) | 2.45529625 |
| 90 | Generalized hypopigmentation of hair (HP:0011358) | 2.45252481 |
| 91 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.44843969 |
| 92 | Metabolic acidosis (HP:0001942) | 2.43035992 |
| 93 | Abnormality of chloride homeostasis (HP:0011422) | 2.42578417 |
| 94 | Hypomagnesemia (HP:0002917) | 2.42316167 |
| 95 | Attenuation of retinal blood vessels (HP:0007843) | 2.42028293 |
| 96 | Cardiovascular calcification (HP:0011915) | 2.41860262 |
| 97 | Neurofibrillary tangles (HP:0002185) | 2.39771264 |
| 98 | Status epilepticus (HP:0002133) | 2.38852220 |
| 99 | Abnormality of serum amino acid levels (HP:0003112) | 2.38828357 |
| 100 | Fair hair (HP:0002286) | 2.35327932 |
| 101 | Inability to walk (HP:0002540) | 2.33897268 |
| 102 | Polyuria (HP:0000103) | 2.33305924 |
| 103 | Calf muscle hypertrophy (HP:0008981) | 2.32800994 |
| 104 | Protruding tongue (HP:0010808) | 2.31670156 |
| 105 | Nephronophthisis (HP:0000090) | 2.31162405 |
| 106 | Facial diplegia (HP:0001349) | 2.30529116 |
| 107 | Enlarged kidneys (HP:0000105) | 2.30478590 |
| 108 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.29030957 |
| 109 | Prominent supraorbital ridges (HP:0000336) | 2.27521414 |
| 110 | Systemic lupus erythematosus (HP:0002725) | 2.26706711 |
| 111 | Ventricular fibrillation (HP:0001663) | 2.26672826 |
| 112 | Large for gestational age (HP:0001520) | 2.25563982 |
| 113 | Abnormal drinking behavior (HP:0030082) | 2.23507276 |
| 114 | Polydipsia (HP:0001959) | 2.23507276 |
| 115 | Chronic hepatic failure (HP:0100626) | 2.22959753 |
| 116 | Abnormality of the calf musculature (HP:0001430) | 2.22885266 |
| 117 | Abnormal gallbladder physiology (HP:0012438) | 2.22680734 |
| 118 | Cholecystitis (HP:0001082) | 2.22680734 |
| 119 | Hyperbilirubinemia (HP:0002904) | 2.22183004 |
| 120 | Abnormality of the renal cortex (HP:0011035) | 2.21607604 |
| 121 | Cystic liver disease (HP:0006706) | 2.21166340 |
| 122 | Rhinitis (HP:0012384) | 2.20915262 |
| 123 | Hyperuricemia (HP:0002149) | 2.20837570 |
| 124 | Increased purine levels (HP:0004368) | 2.20837570 |
| 125 | Abnormal EKG (HP:0003115) | 2.20709838 |
| 126 | Infertility (HP:0000789) | 2.19299760 |
| 127 | Asymmetric septal hypertrophy (HP:0001670) | 2.18122085 |
| 128 | Febrile seizures (HP:0002373) | 2.15806642 |
| 129 | Type II lissencephaly (HP:0007260) | 2.15390555 |
| 130 | Steatorrhea (HP:0002570) | 2.15303994 |
| 131 | Furrowed tongue (HP:0000221) | 2.15112487 |
| 132 | Chorioretinal atrophy (HP:0000533) | 2.14351149 |
| 133 | Hemorrhage of the eye (HP:0011885) | 2.14285086 |
| 134 | Tubulointerstitial nephritis (HP:0001970) | 2.13761922 |
| 135 | Hypophosphatemic rickets (HP:0004912) | 2.13542165 |
| 136 | Hepatocellular carcinoma (HP:0001402) | 2.13172566 |
| 137 | Chronic bronchitis (HP:0004469) | 2.12046333 |
| 138 | Abnormal atrioventricular conduction (HP:0005150) | 2.11791526 |
| 139 | Abnormality of T cell number (HP:0011839) | 2.08894842 |
| 140 | Renal cortical cysts (HP:0000803) | 2.08604851 |
| 141 | Renal salt wasting (HP:0000127) | 2.07271319 |
| 142 | Sensorimotor neuropathy (HP:0007141) | 2.07025819 |
| 143 | Tubulointerstitial abnormality (HP:0001969) | 2.06736150 |
| 144 | Widely spaced teeth (HP:0000687) | 2.06287779 |
| 145 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.04779176 |
| 146 | Proximal tubulopathy (HP:0000114) | 2.04442187 |
| 147 | Cerebral inclusion bodies (HP:0100314) | 2.04027729 |
| 148 | Atrioventricular block (HP:0001678) | 2.02936030 |
| 149 | Hypoglycemic coma (HP:0001325) | 2.01412440 |
| 150 | Stomach cancer (HP:0012126) | 2.00737857 |
| 151 | Abnormality of secondary sexual hair (HP:0009888) | 1.99206394 |
| 152 | Abnormality of the axillary hair (HP:0100134) | 1.99206394 |
| 153 | Hypoplastic ischia (HP:0003175) | 1.98068241 |
| 154 | Lethargy (HP:0001254) | 1.97726537 |
| 155 | Ventricular arrhythmia (HP:0004308) | 1.97572151 |
| 156 | Myocardial infarction (HP:0001658) | 1.96963376 |
| 157 | Pancreatitis (HP:0001733) | 1.95118913 |
| 158 | Increased corneal curvature (HP:0100692) | 1.93665621 |
| 159 | Keratoconus (HP:0000563) | 1.93665621 |
| 160 | Irritability (HP:0000737) | 1.93097464 |
| 161 | Focal motor seizures (HP:0011153) | 1.93070934 |
| 162 | Palpitations (HP:0001962) | 1.93062791 |
| 163 | Metaphyseal dysplasia (HP:0100255) | 1.92653334 |
| 164 | Amyloidosis (HP:0011034) | 1.92251191 |
| 165 | Hypokalemia (HP:0002900) | 1.92123484 |
| 166 | Acanthocytosis (HP:0001927) | 1.91074239 |
| 167 | Tubulointerstitial fibrosis (HP:0005576) | 1.90801158 |
| 168 | T lymphocytopenia (HP:0005403) | 1.90792323 |
| 169 | Rickets (HP:0002748) | 1.89763701 |
| 170 | Broad ribs (HP:0000885) | 1.88651608 |
| 171 | Abnormality of potassium homeostasis (HP:0011042) | 1.87261432 |
| 172 | Malnutrition (HP:0004395) | 1.87074237 |
| 173 | Absent speech (HP:0001344) | 1.86977296 |
| 174 | Progressive inability to walk (HP:0002505) | 1.86407508 |
| 175 | Neonatal onset (HP:0003623) | 1.86075086 |
| 176 | Medial flaring of the eyebrow (HP:0010747) | 1.85125327 |
| 177 | Generalized aminoaciduria (HP:0002909) | 1.83981040 |
| 178 | Pigmentary retinal degeneration (HP:0001146) | 1.82756198 |
| 179 | Hypoproteinemia (HP:0003075) | 1.79325473 |
| 180 | Broad-based gait (HP:0002136) | 1.78532492 |
| 181 | Abnormality of the ischium (HP:0003174) | 1.77821051 |
| 182 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.75009175 |
| 183 | Subaortic stenosis (HP:0001682) | 1.75009175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK3 | 3.77296517 |
| 2 | PDK4 | 3.77296517 |
| 3 | OXSR1 | 3.45075702 |
| 4 | STK39 | 3.32450150 |
| 5 | PDK2 | 3.24094824 |
| 6 | WNK4 | 3.21221198 |
| 7 | BCKDK | 2.98962057 |
| 8 | EPHA4 | 2.93193402 |
| 9 | WNK3 | 2.50717058 |
| 10 | ACVR1B | 2.31927580 |
| 11 | CASK | 2.23995427 |
| 12 | TXK | 2.14898810 |
| 13 | DAPK2 | 2.14451878 |
| 14 | ADRBK2 | 2.12514761 |
| 15 | BMPR1B | 2.11030876 |
| 16 | NTRK3 | 2.05447360 |
| 17 | SIK1 | 2.00661456 |
| 18 | INSRR | 1.96080898 |
| 19 | OBSCN | 1.95568060 |
| 20 | MARK1 | 1.95030947 |
| 21 | FRK | 1.93932673 |
| 22 | TRPM7 | 1.91267330 |
| 23 | AKT3 | 1.82297244 |
| 24 | PAK3 | 1.76113917 |
| 25 | MST1R | 1.72537557 |
| 26 | MAP2K4 | 1.67544671 |
| 27 | TAOK3 | 1.58020060 |
| 28 | NEK9 | 1.50436874 |
| 29 | GRK7 | 1.48345581 |
| 30 | PTK2B | 1.43895604 |
| 31 | ADRBK1 | 1.43891259 |
| 32 | MAP2K7 | 1.43802712 |
| 33 | CAMK1G | 1.41790098 |
| 34 | ICK | 1.38832030 |
| 35 | NLK | 1.36582190 |
| 36 | MAP3K4 | 1.36160130 |
| 37 | STK38 | 1.35567991 |
| 38 | PRKD3 | 1.34670564 |
| 39 | TGFBR1 | 1.17017307 |
| 40 | TEC | 1.16031478 |
| 41 | TNIK | 1.14728229 |
| 42 | SGK223 | 1.12836633 |
| 43 | SGK494 | 1.12836633 |
| 44 | ITK | 1.09800310 |
| 45 | SGK2 | 1.09255195 |
| 46 | TIE1 | 1.09089029 |
| 47 | RIPK4 | 1.06358250 |
| 48 | TGFBR2 | 1.01983567 |
| 49 | PINK1 | 1.00315055 |
| 50 | LATS1 | 0.99214901 |
| 51 | PKN1 | 0.98209337 |
| 52 | PDK1 | 0.97298992 |
| 53 | SIK2 | 0.95874608 |
| 54 | MINK1 | 0.91640650 |
| 55 | KIT | 0.91013584 |
| 56 | TTN | 0.90277338 |
| 57 | CAMK1D | 0.88893886 |
| 58 | PRKCG | 0.88040736 |
| 59 | PDPK1 | 0.87484073 |
| 60 | ERN1 | 0.87264246 |
| 61 | TLK1 | 0.87171944 |
| 62 | MUSK | 0.84538900 |
| 63 | JAK1 | 0.84497304 |
| 64 | SYK | 0.83257216 |
| 65 | BRSK2 | 0.83075678 |
| 66 | WNK1 | 0.83052527 |
| 67 | SGK3 | 0.81918378 |
| 68 | MAP4K2 | 0.81910599 |
| 69 | FGFR2 | 0.80319263 |
| 70 | MAPK12 | 0.78776686 |
| 71 | PRKCZ | 0.76539429 |
| 72 | CAMKK1 | 0.76492067 |
| 73 | FGFR4 | 0.75663464 |
| 74 | ERBB4 | 0.75619053 |
| 75 | PNCK | 0.75101126 |
| 76 | CAMK2A | 0.73794919 |
| 77 | NTRK2 | 0.71906386 |
| 78 | PIK3CG | 0.68892522 |
| 79 | MAPK15 | 0.67816626 |
| 80 | NUAK1 | 0.67330191 |
| 81 | MAPKAPK3 | 0.67089238 |
| 82 | TESK1 | 0.66134592 |
| 83 | EPHA3 | 0.65544821 |
| 84 | DMPK | 0.63731487 |
| 85 | STK38L | 0.63474766 |
| 86 | BLK | 0.62738971 |
| 87 | DAPK1 | 0.62417645 |
| 88 | MAP2K6 | 0.61566434 |
| 89 | NEK6 | 0.61350333 |
| 90 | PRKAA2 | 0.61002377 |
| 91 | PDGFRB | 0.60842090 |
| 92 | MELK | 0.60784355 |
| 93 | CAMK4 | 0.60078102 |
| 94 | SGK1 | 0.58480770 |
| 95 | MAP3K2 | 0.58017218 |
| 96 | PRKCQ | 0.57818607 |
| 97 | ZAK | 0.56795001 |
| 98 | CSNK1G2 | 0.56638358 |
| 99 | TNK2 | 0.56443913 |
| 100 | MAP3K7 | 0.56369803 |
| 101 | PRKACA | 0.55322374 |
| 102 | CAMK1 | 0.55221334 |
| 103 | MARK2 | 0.54207004 |
| 104 | IRAK2 | 0.53361828 |
| 105 | PAK6 | 0.53113925 |
| 106 | CDK5 | 0.52530509 |
| 107 | IRAK1 | 0.52494155 |
| 108 | MAPKAPK5 | 0.52117727 |
| 109 | STK24 | 0.51438521 |
| 110 | MAPK7 | 0.51376368 |
| 111 | MAPK13 | 0.50585563 |
| 112 | MAP3K6 | 0.49981607 |
| 113 | GRK1 | 0.49625560 |
| 114 | PRKAA1 | 0.48890098 |
| 115 | MAP4K1 | 0.48747807 |
| 116 | STK16 | 0.48704605 |
| 117 | CAMK2D | 0.48335110 |
| 118 | PRKCH | 0.47318410 |
| 119 | CAMK2G | 0.46635677 |
| 120 | RPS6KA6 | 0.46117867 |
| 121 | MAP3K9 | 0.45188150 |
| 122 | FER | 0.45150757 |
| 123 | LCK | 0.44250437 |
| 124 | PRKACG | 0.44091704 |
| 125 | PIK3CA | 0.43831738 |
| 126 | MAP2K1 | 0.43152794 |
| 127 | IKBKB | 0.43141796 |
| 128 | STK3 | 0.42266122 |
| 129 | PRKD1 | 0.42052024 |
| 130 | GRK5 | 0.41802587 |
| 131 | CAMK2B | 0.41563308 |
| 132 | BMPR2 | 0.40956111 |
| 133 | MAPK4 | 0.40632065 |
| 134 | BTK | 0.40377786 |
| 135 | NTRK1 | 0.39761607 |
| 136 | PRKCE | 0.39681168 |
| 137 | ERBB3 | 0.39116471 |
| 138 | CCNB1 | 0.38733034 |
| 139 | PLK2 | 0.36713149 |
| 140 | CAMKK2 | 0.35718923 |
| 141 | PRKCA | 0.35588542 |
| 142 | PRKG1 | 0.35449058 |
| 143 | STK11 | 0.35060543 |
| 144 | MYLK | 0.33666479 |
| 145 | FES | 0.32963489 |
| 146 | FYN | 0.32518465 |
| 147 | ABL2 | 0.31163693 |
| 148 | MET | 0.30787005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.57764721 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.03146439 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.88711772 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.81337039 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.75675825 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.50018687 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.37901784 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.35070320 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.32204410 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.30522587 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.22970773 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.19911731 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.16688549 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.10597292 |
| 15 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.08715862 |
| 16 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.00869533 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.00866582 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.94604241 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.92969973 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.91651912 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.88487278 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.87732200 |
| 23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.86437459 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.82341967 |
| 25 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.75500518 |
| 26 | Phototransduction_Homo sapiens_hsa04744 | 1.74937169 |
| 27 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.74849862 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.74709918 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73322092 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70486470 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.69808906 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.67877894 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.63344336 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.61782786 |
| 35 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.59218047 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.56109641 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51555490 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.51476712 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.48109450 |
| 40 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.45874690 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.45360300 |
| 42 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.42392205 |
| 43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.37190856 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.32749234 |
| 45 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.31442823 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29574243 |
| 47 | Circadian rhythm_Homo sapiens_hsa04710 | 1.26264837 |
| 48 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.24713225 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.24389493 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.22968341 |
| 51 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.21017572 |
| 52 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.18050365 |
| 53 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.15798243 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11910209 |
| 55 | Olfactory transduction_Homo sapiens_hsa04740 | 1.11310817 |
| 56 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.10658449 |
| 57 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10433979 |
| 58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.08591604 |
| 59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.08560113 |
| 60 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.08131665 |
| 61 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.05894198 |
| 62 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.04474410 |
| 63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.03492994 |
| 64 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.03080536 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.02523560 |
| 66 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.01132681 |
| 67 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.98926634 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.98658441 |
| 69 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.96859828 |
| 70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96515740 |
| 71 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95132805 |
| 72 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.91613482 |
| 73 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.88975511 |
| 74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88959380 |
| 75 | Platelet activation_Homo sapiens_hsa04611 | 0.85105128 |
| 76 | Nicotine addiction_Homo sapiens_hsa05033 | 0.83811081 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82585950 |
| 78 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.81768784 |
| 79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.80275534 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79897282 |
| 81 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78434505 |
| 82 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.78029932 |
| 83 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78007409 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77813066 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.74452803 |
| 86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.71930296 |
| 87 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.70393273 |
| 88 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.68256624 |
| 89 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.67678545 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.66973597 |
| 91 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66707981 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.65680081 |
| 93 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64707765 |
| 94 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63197361 |
| 95 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.58526293 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58336795 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57667448 |
| 98 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54772174 |
| 99 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.53822582 |
| 100 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.53383313 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52897551 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52039041 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51701842 |
| 104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.51378286 |
| 105 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.50697728 |
| 106 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.50374924 |
| 107 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49793398 |
| 108 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47373741 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46820306 |
| 110 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46244812 |
| 111 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.45716881 |
| 112 | Long-term depression_Homo sapiens_hsa04730 | 0.45580447 |
| 113 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.45486624 |
| 114 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.44769608 |
| 115 | Alzheimers disease_Homo sapiens_hsa05010 | 0.44723655 |
| 116 | Parkinsons disease_Homo sapiens_hsa05012 | 0.44471523 |
| 117 | Allograft rejection_Homo sapiens_hsa05330 | 0.42626178 |
| 118 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41659106 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38965176 |
| 120 | Salivary secretion_Homo sapiens_hsa04970 | 0.38217546 |
| 121 | GABAergic synapse_Homo sapiens_hsa04727 | 0.38103909 |
| 122 | Renin secretion_Homo sapiens_hsa04924 | 0.37380173 |
| 123 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.37328364 |
| 124 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.34520252 |
| 125 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.33759907 |
| 126 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33485096 |
| 127 | Mineral absorption_Homo sapiens_hsa04978 | 0.28323494 |
| 128 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.27105289 |
| 129 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25575389 |
| 130 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.25552870 |
| 131 | Circadian entrainment_Homo sapiens_hsa04713 | 0.25525812 |
| 132 | Sulfur relay system_Homo sapiens_hsa04122 | 0.24050923 |
| 133 | Morphine addiction_Homo sapiens_hsa05032 | 0.23999683 |
| 134 | Taste transduction_Homo sapiens_hsa04742 | 0.23982941 |
| 135 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.23875007 |
| 136 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.22833367 |
| 137 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.22204478 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21857689 |
| 139 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21523083 |
| 140 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.20572939 |
| 141 | Long-term potentiation_Homo sapiens_hsa04720 | 0.19183659 |
| 142 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.19037218 |
| 143 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.18440893 |
| 144 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.17887029 |
| 145 | Insulin secretion_Homo sapiens_hsa04911 | 0.16997697 |
| 146 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.16501237 |
| 147 | Insulin resistance_Homo sapiens_hsa04931 | 0.14975965 |
| 148 | Cocaine addiction_Homo sapiens_hsa05030 | 0.12423121 |

